← Back to Search

Chemotherapy

Observational (non-study chemo, questionnaire, assessments) for Ovarian Cancer

N/A
Waitlist Available
Led By Meghna S Trivedi
Research Sponsored by SWOG Cancer Research Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 52 weeks
Awards & highlights

Summary

This trial studies treatment effects on development of chemotherapy-induced peripheral neuropathy in patients with cancer. Treatments for cancer can cause a problem to the nervous system (called peripheral neuropathy) that can lead to tingling or less feeling in hands and feet. Studying certain risk factors, such as age, gender, pre-existing conditions, and the type of treatment for cancer may help doctors estimate how likely patients are to develop the nerve disorder.

Eligible Conditions
  • Ovarian Cancer
  • Lung Cancer
  • Breast Cancer
  • Non-Small Cell Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 52 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 52 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Development of peripheral neuropathy
Secondary outcome measures
Assess incidence of CIPN
CIPN symptoms
Dose Changes
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (non-study chemo, questionnaire, assessments)Experimental Treatment3 Interventions
Patients receive chemotherapy regimen per treating physician for 52 weeks in the absence of disease progression or unacceptable toxicity. Patients also complete questionnaires at weeks 4, 8, 12, 24 and 52.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Chemotherapy
2003
Completed Phase 4
~3050

Find a Location

Who is running the clinical trial?

SWOG Cancer Research NetworkLead Sponsor
395 Previous Clinical Trials
263,812 Total Patients Enrolled
11 Trials studying Ovarian Cancer
1,830 Patients Enrolled for Ovarian Cancer
National Cancer Institute (NCI)NIH
13,748 Previous Clinical Trials
40,958,065 Total Patients Enrolled
289 Trials studying Ovarian Cancer
73,705 Patients Enrolled for Ovarian Cancer
Southwest Oncology GroupLead Sponsor
388 Previous Clinical Trials
259,925 Total Patients Enrolled
11 Trials studying Ovarian Cancer
1,830 Patients Enrolled for Ovarian Cancer
~97 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top